NCT04851119 2026-02-24Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsChildren's Oncology GroupPhase 1/2 Recruiting147 enrolled
NCT00716976 2023-11-09Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyChildren's Oncology GroupPhase 3 Completed131 enrolled 18 charts 2 FDA
NCT00002485 2014-02-14Development of Strategies to Increase Enrollment in Clinical Trials for Children With CancerChildren's Oncology GroupCompleted359 enrolled